ATE244727T1 - Tetrapeptid, das die funktionelle aktivität von neuronen stimuliert, dieses enthaltendes pharmakologisches mittel und seine verwendung - Google Patents

Tetrapeptid, das die funktionelle aktivität von neuronen stimuliert, dieses enthaltendes pharmakologisches mittel und seine verwendung

Info

Publication number
ATE244727T1
ATE244727T1 AT00937408T AT00937408T ATE244727T1 AT E244727 T1 ATE244727 T1 AT E244727T1 AT 00937408 T AT00937408 T AT 00937408T AT 00937408 T AT00937408 T AT 00937408T AT E244727 T1 ATE244727 T1 AT E244727T1
Authority
AT
Austria
Prior art keywords
functional activity
tetrapeptide
salts
proposed
neurones
Prior art date
Application number
AT00937408T
Other languages
English (en)
Inventor
Vladimir Khatskelevi Khavinson
Vyacheslav Grigorievic Morozov
Vladimir Viktorovich Malinin
Evgeny Iosifovich Grigoriev
Original Assignee
Sankt Peterburgskaya Obschestv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankt Peterburgskaya Obschestv filed Critical Sankt Peterburgskaya Obschestv
Application granted granted Critical
Publication of ATE244727T1 publication Critical patent/ATE244727T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00937408T 1999-10-20 2000-05-25 Tetrapeptid, das die funktionelle aktivität von neuronen stimuliert, dieses enthaltendes pharmakologisches mittel und seine verwendung ATE244727T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU99121778/14A RU2155063C1 (ru) 1999-10-20 1999-10-20 Тетрапептид, стимулирующий функциональную активность нейронов, фармакологическое средство на его основе и способ его применения
PCT/RU2000/000218 WO2001029067A1 (en) 1999-10-20 2000-05-25 Tetrapeptide stimulating functional activity of neurones, pharmacological agent based thereon and method of use thereof

Publications (1)

Publication Number Publication Date
ATE244727T1 true ATE244727T1 (de) 2003-07-15

Family

ID=20225904

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00937408T ATE244727T1 (de) 1999-10-20 2000-05-25 Tetrapeptid, das die funktionelle aktivität von neuronen stimuliert, dieses enthaltendes pharmakologisches mittel und seine verwendung

Country Status (10)

Country Link
US (1) US7189701B1 (de)
EP (1) EP1224212B1 (de)
JP (1) JP4668497B2 (de)
AT (1) ATE244727T1 (de)
AU (1) AU784578B2 (de)
CA (1) CA2388357A1 (de)
DE (1) DE60003837T2 (de)
IL (1) IL149243A0 (de)
RU (1) RU2155063C1 (de)
WO (1) WO2001029067A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US7175679B2 (en) 2001-03-29 2007-02-13 Biotempt B.V. Oligopeptide treatment of NF-κB mediated inflammation
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
EP1138692A1 (de) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragmente des menschlichen Choriongonadotropins als Immunoregulatoren
US6921751B1 (en) 1998-05-20 2005-07-26 Erasmus Universiteit Rotterdam Immunoregulator
US7576174B2 (en) 2000-03-29 2009-08-18 Biotempt B.V. Compositions capable of reducing elevated blood urea concentration
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
EP1300418A1 (de) 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Genregulation durch Oligopeptide
RU2161501C1 (ru) * 2000-06-29 2001-01-10 Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" Способ получения пептидов, обладающих тканеспецифической активностью, и фармацевтические композиции на их основе
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US7501391B2 (en) 2001-12-21 2009-03-10 Biotempt B.V. Treatment of transplant survival
RU2244928C2 (ru) * 2003-02-19 2005-01-20 Пинигина Нина Максимовна Эндогенная фармацевтическая композиция, полученная на основе целенаправленной активации гуморальных медиаторов нервных окончаний коры головного мозга
WO2007004869A2 (en) 2005-07-05 2007-01-11 Biotempt B.V. Treatment of tumors
EP1864692A1 (de) 2006-06-07 2007-12-12 Biotempt B.V. Verwendung von peptiden zum Schutz von Strahlenschäden
EP1857463A1 (de) * 2006-05-03 2007-11-21 Ebewe Pharma Ges.m.b.H. Nfg. KG Neuroprotektive Wirkungen von Peptide
RU2301678C1 (ru) * 2006-05-30 2007-06-27 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Пептид, стимулирующий регенерацию нейронов центральной нервной системы, фармацевтическая композиция на его основе и способ ее применения
EP2000134A1 (de) * 2007-06-06 2008-12-10 Neuraxo Biopharmaceuticals GmbH Verwendung einer Substanz zur Behandlung von Verletzungen des peripheren Nervensystems
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
EA020866B1 (ru) 2013-02-28 2015-02-27 Замертон Холдингс Лимитед Пептиды с цитопротекторной активностью и фармацевтическая композиция
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
US20220185855A1 (en) * 2019-01-25 2022-06-16 University of Texas-Medical Branch (TMB) Novel non-opioid anti-pain medication
RU2768475C1 (ru) * 2021-07-08 2022-03-24 Общество с ограниченной ответственностью "ТЕРРАНОВА КАПИТАЛ" Пептид, обладающий нейростимулирующей активностью и восстанавливающий способность к обучению и формированию памяти, фармацевтическая композиция на его основе и способ ее применения

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652334A (en) * 1993-09-08 1997-07-29 City Of Hope Method for design of substances that enhance memory and improve the quality of life

Also Published As

Publication number Publication date
IL149243A0 (en) 2002-11-10
AU784578B2 (en) 2006-05-04
EP1224212A1 (de) 2002-07-24
RU2155063C1 (ru) 2000-08-27
EP1224212B1 (de) 2003-07-09
WO2001029067A1 (en) 2001-04-26
US7189701B1 (en) 2007-03-13
DE60003837T2 (de) 2004-06-03
JP4668497B2 (ja) 2011-04-13
JP2003532630A (ja) 2003-11-05
CA2388357A1 (en) 2001-04-26
DE60003837D1 (de) 2003-08-14
AU5258500A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
ATE244727T1 (de) Tetrapeptid, das die funktionelle aktivität von neuronen stimuliert, dieses enthaltendes pharmakologisches mittel und seine verwendung
ATE321068T1 (de) Alterungsschutztetrapeptid, dieses enthaltende pharmazeutische zusammensetzungen und seine verwendung
EA200300046A1 (ru) Быстро увеличивающаяся в объеме композиция для удерживания и контролированного выделения терапевтических агентов в желудке и лекарственные формы, включающие композицию
DE69909794D1 (de) Verwendung eines dipeptids für wiederherstellungsprozesse
NO20043871L (no) Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
NO20022442D0 (no) Legemidler for sykdommer i forbindelse med reduksjon i benmasse
IT1187828B (it) Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
TR200101633T2 (tr) Farmasötik bileşim
IL194500A0 (en) Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application
ATE513845T1 (de) Peptidsubstanz mit immunogeroprotektiver wirkung, darauf basierende pharmazeutische zusammensetzung und verfahren zu ihrer anwendung
AU3231901A (en) Phenoxyalkylamine derivatives useful as opioid delta receptor agonists
ES2042818T3 (es) Agente terapeutico para la trombocitopenia.
DE68907268T2 (de) Verwendung von Phytinsäure als Antidot gegen Alkoholvergiftung.
CA2425445A1 (en) Tetrapeptide stimulating functional activity of hepatocytes, pharmacological substance on its basis and the method of its application
CA2547873A1 (en) Tetrapeptide regulating blood glucose level in diabetes mellitus
BR0317292A (pt) Derivados de amida de ácido antranìlico e seu uso farmacêutico
HUP0303754A2 (hu) Gyökfogó vegyületek alkalmazása NO-függő mikrokeringési zavarok kezelésére és megelőzésére szolgáló gyógyszerkészítmény előállítására
NO20013480D0 (no) Legemiddel for törr hud
EA200601581A1 (ru) Пептид, стимулирующий регенерацию ткани печени, фармацевтическая композиция на его основе и способ ее применения
SE9903610D0 (sv) Novel compounds II
RU95102718A (ru) Способ коррекции иммунного статуса у вич-инфицированных больных
RU2007143336A (ru) Фармацевтическая композиция на основе пептида, нормализующего мочеиспускание, и способ ее применения
RU2001112719A (ru) Способ лечения стенокардии и алекситимии у больных пожилого возраста
TH16073A (th) วิธีการใช้ เฮสเพอเรทิน เพื่อการควบคุมไขผิวหนังและการบำบัดสิว
RU95110719A (ru) Способ лечения инфаркта миокарда

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1224212

Country of ref document: EP

EEIH Change in the person of patent owner